Back to Search Start Over

African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.

Authors :
Boivin, Michael J.
Chernoff, Miriam
Fairlie, Lee
Laughton, Barbara
Zimmer, Bonnie
Joyce, Celeste
Barlow-Mosha, Linda
Bwakura-Dangarembizi, Mutsawashe
Vhembo, Tichaona
Ratswana, Mmule
Kamthunzi, Portia
McCarthy, Katie
Familiar-Lopez, Itziar
Jean-Philippe, Patrick
Coetzee, Joan
Abrahams, Nasreen
Gous, Hermien
Violari, Avy
Cotton, Mark F.
Palumbo, Paul E.
Source :
Clinical Infectious Diseases. Oct2020, Vol. 71 Issue 7, pe105-e114. 10p.
Publication Year :
2020

Abstract

Background. Children living with human immunodeficiency virus (HIV) are at neuropsychological risk for cognitive and motor dysfunction. However, few prospective, multi-site studies have evaluated neuropsychological outcomes longitudinally among perinatally infected African children who received early antiretroviral treatment (ART). Methods. We enrolled 611 children aged 5 to 11 years at 6 sites (South Africa [3], Zimbabwe, Malawi, Uganda). Of these, there were 246 children living with HIV (HIV+) who were initiated on ART before 3 years of age in a prior clinical trial comparing nevirapine to lopinavir/ritonavir (International Maternal Pediatric Adolescent Acquired Immunodeficiency Syndrome Clinical Trials [IMPAACT] P1060); 183 age-matched, exposed but uninfected (HEU) children; and 182 unexposed and uninfected (HUU) children. They were compared across 3 assessment time points (Weeks 0, 48, and 96) on cognitive ability (Kaufman Assessment Battery for Children, second edition [KABC-II]), attention/impulsivity (Tests of Variables of Attention [TOVA]), motor proficiency (Bruininks-Oseretsky Test, second edition [BOT-2]), and on the Behavior Rating Inventory of Executive Function (BRIEF). The cohorts were compared using linear mixed models, adjusting for site, child’s age and sex, and selected personal/family control variables. Results. The HIV+ cohort performed significantly worse than the HEU and HUU cohorts for all KABC-II, TOVA, and BOT-2 performance outcomes across all 3 time points (P values < .001). The HUU and HEU cohorts were comparable. For the KABC-II planning/reasoning subtests, the HIV+ children showed less improvement over time than the HUU and HEU groups. The groups did not differ significantly on the BRIEF. Conclusions. Despite initiation of ART in early childhood and good viral suppression at the time of enrollment, the HIV+ group had poorer neuropsychological performance over time, with the gap progressively worsening in planning/reasoning. This can be debilitating for self-management in adolescence [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10584838
Volume :
71
Issue :
7
Database :
Academic Search Index
Journal :
Clinical Infectious Diseases
Publication Type :
Academic Journal
Accession number :
175520164
Full Text :
https://doi.org/10.1093/cid/ciz1088